Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers.

Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, van der Lei J, Pratt N, Norén GN, Li YC, Stang PE, Madigan D, Ryan PB.

Stud Health Technol Inform. 2015;216:574-8.

PMID:
26262116
2.

Use of adjectives in abstracts when reporting results of randomized, controlled trials from industry and academia.

Cepeda MS, Berlin JA, Glasser SC, Battisti WP, Schuemie MJ.

Drugs R D. 2015 Mar;15(1):85-139. doi: 10.1007/s40268-015-0085-9.

3.

The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study.

de Bie S, Coloma PM, Ferrajolo C, Verhamme KM, Trifirò G, Schuemie MJ, Straus SM, Gini R, Herings R, Mazzaglia G, Picelli G, Ghirardi A, Pedersen L, Stricker BH, van der Lei J, Sturkenboom MC; EU-ADR consortium.

Br J Clin Pharmacol. 2015 Aug;80(2):304-14. doi: 10.1111/bcp.12610. Epub 2015 May 20.

PMID:
25683723
4.

Authors' reply to Hennessy and Leonard's comment on "Desideratum for evidence-based epidemiology".

Overhage JM, Ryan PB, Schuemie MJ, Stang PE.

Drug Saf. 2015 Jan;38(1):105-7. doi: 10.1007/s40264-014-0254-8. No abstract available.

PMID:
25511912
5.

Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detection.

Patadia VK, Schuemie MJ, Coloma P, Herings R, van der Lei J, Straus S, Sturkenboom M, Trifirò G.

Int J Clin Pharm. 2015 Feb;37(1):94-104. doi: 10.1007/s11096-014-0044-5. Epub 2014 Dec 9.

PMID:
25488315
6.

Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.

Patadia VK, Coloma P, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G, Fornari C, Pedersen L, van der Lei J, Sturkenboom M, Trifirò G; EU-ADR consortium.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):95-102. doi: 10.1586/17512433.2015.992878. Review.

PMID:
25487079
7.

ContextD: an algorithm to identify contextual properties of medical terms in a Dutch clinical corpus.

Afzal Z, Pons E, Kang N, Sturkenboom MC, Schuemie MJ, Kors JA.

BMC Bioinformatics. 2014 Nov 29;15:373. doi: 10.1186/s12859-014-0373-3.

8.

Similarity-based modeling applied to signal detection in pharmacovigilance.

Vilar S, Ryan PB, Madigan D, Stang PE, Schuemie MJ, Friedman C, Tatonetti NP, Hripcsak G.

CPT Pharmacometrics Syst Pharmacol. 2014 Sep 24;3:e137. doi: 10.1038/psp.2014.35.

9.

Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.

Boyce RD, Ryan PB, Norén GN, Schuemie MJ, Reich C, Duke J, Tatonetti NP, Trifirò G, Harpaz R, Overhage JM, Hartzema AG, Khayter M, Voss EA, Lambert CG, Huser V, Dumontier M.

Drug Saf. 2014 Aug;37(8):557-67. doi: 10.1007/s40264-014-0189-0.

10.

Risk of upper gastrointestinal bleeding from different drug combinations.

Masclee GM, Valkhoff VE, Coloma PM, de Ridder M, Romio S, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G, Scotti L, Pedersen L, Kuipers EJ, van der Lei J, Sturkenboom MC.

Gastroenterology. 2014 Oct;147(4):784-792.e9; quiz e13-4. doi: 10.1053/j.gastro.2014.06.007. Epub 2014 Jun 14.

PMID:
24937265
11.

Can Italian healthcare administrative databases be used to compare regions with respect to compliance with standards of care for chronic diseases?

Gini R, Schuemie MJ, Francesconi P, Lapi F, Cricelli I, Pasqua A, Gallina P, Donato D, Brugaletta S, Donatini A, Marini A, Cricelli C, Damiani G, Bellentani M, van der Lei J, Sturkenboom MC, Klazinga NS.

PLoS One. 2014 May 9;9(5):e95419. doi: 10.1371/journal.pone.0095419. eCollection 2014.

12.

Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series.

Schuemie MJ, Trifirò G, Coloma PM, Ryan PB, Madigan D.

Stat Methods Med Res. 2014 Mar 31. [Epub ahead of print]

PMID:
24685766
13.

Medication-wide association studies.

Ryan PB, Madigan D, Stang PE, Schuemie MJ, Hripcsak G.

CPT Pharmacometrics Syst Pharmacol. 2013 Sep 18;2:e76. doi: 10.1038/psp.2013.52.

14.

Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network.

Ferrajolo C, Coloma PM, Verhamme KM, Schuemie MJ, de Bie S, Gini R, Herings R, Mazzaglia G, Picelli G, Giaquinto C, Scotti L, Avillach P, Pedersen L, Rossi F, Capuano A, van der Lei J, Trifiró G, Sturkenboom MC; EU-ADR consortium.

Drug Saf. 2014 Feb;37(2):99-108. doi: 10.1007/s40264-013-0132-9.

PMID:
24446276
15.

Discussion of "Biomedical informatics: we are what we publish".

Geissbuhler A, Hammond WE, Hasman A, Hussein R, Koppel R, Kulikowski CA, Maojo V, Martin-Sanchez F, Moorman PW, Moura LA, de Quirós FG, Schuemie MJ, Smith B, Talmon J.

Methods Inf Med. 2013;52(6):547-62.

PMID:
24310397
16.

Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?

Valkhoff VE, Schade R, 't Jong GW, Romio S, Schuemie MJ, Arfe A, Garbe E, Herings R, Lucchi S, Picelli G, Schink T, Straatman H, Villa M, Kuipers EJ, Sturkenboom MC; Safety of Non-steroidal Anti-inflammatory Drugs (SOS) project.

BMC Pediatr. 2013 Nov 19;13:192. doi: 10.1186/1471-2431-13-192.

17.

Alternative outcome definitions and their effect on the performance of methods for observational outcome studies.

Reich CG, Ryan PB, Schuemie MJ.

Drug Saf. 2013 Oct;36 Suppl 1:S181-93. doi: 10.1007/s40264-013-0111-1.

PMID:
24166234
18.

Evaluating performance of risk identification methods through a large-scale simulation of observational data.

Ryan PB, Schuemie MJ.

Drug Saf. 2013 Oct;36 Suppl 1:S171-80. doi: 10.1007/s40264-013-0110-2.

PMID:
24166233
19.

Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.

Schuemie MJ, Gini R, Coloma PM, Straatman H, Herings RM, Pedersen L, Innocenti F, Mazzaglia G, Picelli G, van der Lei J, Sturkenboom MC.

Drug Saf. 2013 Oct;36 Suppl 1:S159-69. doi: 10.1007/s40264-013-0109-8.

PMID:
24166232
20.

A comparison of the empirical performance of methods for a risk identification system.

Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, DuMouchel W, Reich CG, Schuemie MJ, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S143-58. doi: 10.1007/s40264-013-0108-9.

PMID:
24166231
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk